RESEARCH ARTICLE elifesciences.org Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to the anti-protozoan drug emetine Wilson Wong1,2†, Xiao-chen Bai3†, Alan Brown3†, Israel S Fernandez3, Eric Hanssen4, Melanie Condron1,2, Yan Hong Tan1,2, Jake Baum1,2*‡, Sjors HW Scheres3* 1Division of Infection and Immunity, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; 2Department of Medical Biology, University of Melbourne, Melbourne, Australia; 3Structural Studies, Medical Research Council Laboratory of Molecular Biology, Cambridge, United Kingdom; 4Electron Microscopy Unit, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Australia Abstract Malaria inflicts an enormous burden on global human health. The emergence of parasite resistance to front-line drugs has prompted a renewed focus on the repositioning of clinically approved drugs as potential anti-malarial therapies. Antibiotics that inhibit protein translation are promising candidates for repositioning. We have solved the cryo-EM structure of the cytoplasmic *For correspondence: jake. ribosome from the human malaria parasite, Plasmodium falciparum, in complex with emetine at
[email protected] (JB); 3.2 Å resolution. Emetine is an anti-protozoan drug used in the treatment of ameobiasis that also
[email protected] displays potent anti-malarial activity. Emetine interacts with the E-site of the ribosomal small subunit (SHWS) and shares a similar binding site with the antibiotic pactamycin, thereby delivering its therapeutic †These authors contributed effect by blocking mRNA/tRNA translocation. As the first cryo-EM structure that visualizes an equally to this work antibiotic bound to any ribosome at atomic resolution, this establishes cryo-EM as a powerful tool Present address: ‡Department for screening and guiding the design of drugs that target parasite translation machinery.